JHVEPhoto
Eli Lilly (NYSE:LLY) has received a positive recommendation for approval from European regulators for its drug Omvoh in the treatment of Crohn’s disease.
The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion for